BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31006848)

  • 1. Office-based dermatologic diagnostic procedure utilization in the United States Medicare population from 2000-2016.
    Guzman AK; Kaffenberger BH
    Int J Dermatol; 2019 Nov; 58(11):1317-1322. PubMed ID: 31006848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic Distribution of Nonphysician Clinicians Who Independently Billed Medicare for Common Dermatologic Services in 2014.
    Adamson AS; Suarez EA; McDaniel P; Leiphart PA; Zeitany A; Kirby JS
    JAMA Dermatol; 2018 Jan; 154(1):30-36. PubMed ID: 29167867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016.
    Skaggs R; Coldiron B
    J Am Acad Dermatol; 2021 Jan; 84(1):53-59. PubMed ID: 32553682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in Medicare Reimbursement in Radiation Oncology: An Analysis of the Medicare Provider Utilization and Payment Data Set.
    Vu CC; Lanni TB; Robertson JM
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1000-5. PubMed ID: 27026306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managed care and the treatment of skin disease, 1995. Continued growth and emerging dominance.
    Stern RS
    Arch Dermatol; 1998 Sep; 134(9):1089-91. PubMed ID: 9762019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Dermatologist Density With the Volume and Costs of Dermatology Procedures Among Medicare Beneficiaries.
    Tan SY; Tsoucas D; Mostaghimi A
    JAMA Dermatol; 2018 Jan; 154(1):73-76. PubMed ID: 29188286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Use of Radiotherapy Among Dermatologists From 2013 to 2017.
    Nguyen KD; Chen HW; Adamson AS
    JAMA Dermatol; 2021 Mar; 157(3):322-325. PubMed ID: 33355610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What has the Clinical Laboratory Improvement Act of 1988 done to potassium hydroxide (KOH) staining?
    Manivannan M; Diven D
    Int J Dermatol; 2019 Jul; 58(7):861-862. PubMed ID: 30972729
    [No Abstract]   [Full Text] [Related]  

  • 9. Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.
    Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Weinstock MA; Elmore JG; Tosteson ANA
    Br J Dermatol; 2017 Sep; 177(3):845-853. PubMed ID: 28369774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower utilization of dermatologists in managed care: despite growth in managed care, visits to dermatologists did not decrease: an analysis of National Ambulatory Medical Care Survey data, 1990-1992.
    Feldman SR; Williford PM; Fleischer AB
    J Invest Dermatol; 1996 Dec; 107(6):860-4. PubMed ID: 8941675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013.
    Johnstone C; Joiner KA; Pierce J; Krouse RS
    Am J Clin Oncol; 2018 Dec; 41(12):1199-1203. PubMed ID: 29672366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population.
    Cao S; Karmouta R; Li DG; Din RS; Mostaghimi A
    JAMA Dermatol; 2018 Mar; 154(3):317-322. PubMed ID: 29417134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.
    Roetzheim RG; Lee JH; Ferrante JM; Gonzalez EC; Chen R; Fisher KJ; Love-Jackson K; McCarthy EP
    J Am Board Fam Med; 2013; 26(6):637-47. PubMed ID: 24204060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site of Treatment for Non-Urgent Conditions by Medicare Beneficiaries: Is There a Role for Urgent Care Centers?
    Corwin GS; Parker DM; Brown JR
    Am J Med; 2016 Sep; 129(9):966-73. PubMed ID: 27083513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coding multiple diagnoses for patient visits at which procedures were performed: no evidence for abuse by physicians.
    Feldman SR; Fleischer AB; Shaffer CL; Kiang SH; Williford PM; Lupton FA; Chen GJ
    Dermatol Surg; 2003 Feb; 29(2):150-4. PubMed ID: 12562344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Medicare Office Visit Payment Reform on Urologic Practices.
    Modi PK; Kaufman SR; Caram MV; Ellimoottil C; Shahinian VB; Hollenbeck BK
    Urology; 2019 Apr; 126():83-88. PubMed ID: 30682462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Analysis of Medicare Reimbursement for Neurosurgeon Office Visits: 2010 Compared to 2018.
    Harrington MT; Pollock JR; Haglin JM; Richter KR; Patel NP
    Neurosurgery; 2021 Jun; 89(1):E42-E48. PubMed ID: 34000736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scope of physician procedures independently billed by mid-level providers in the office setting.
    Coldiron B; Ratnarathorn M
    JAMA Dermatol; 2014 Nov; 150(11):1153-9. PubMed ID: 25110923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the limited generalist (no hospital, no procedures) model on the viability of family practice training.
    Rodney WM; Hahn RG
    J Am Board Fam Pract; 2002; 15(3):191-200. PubMed ID: 12038725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Medicare cost comparison of minor cutaneous procedures by surgical setting.
    Marks MM; Yelverton CB; Williford PM; Teuschler HV; Coloe J; Chen J; Feldman SR
    J Dermatolog Treat; 2010 Mar; 21(2):101-6. PubMed ID: 19459078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.